MECP2 and myocardial infarction: Researchers found that bone marrow-derived MSC (BMSC) from mice after ischemic preconditioning could secrete miR-22 highly enriched exosomes, and in the MI mouse model, miR-22 targeted methyl CpG binding protein 2 (Mecp2) to reduce infarct size and cardiac fibrosis (66).